Literature DB >> 23754356

Th1/Th2 cytokines in patients with Graves' disease with or without ophthalmopathy.

Fatemeh Esfahanian1, Effat Naimi, Farideh Doroodgar, Zohre Jadali.   

Abstract

About 25-50% of Graves' disease (GD) patients develop thyroid eye diseases, which is associated with inflammatory process and abnormalities in the levels of several cytokines in orbital tissues in GD. The aim of this study was to determine the Th1 and Th2 serum cytokines in patients with GD with or without ophthalmopathy. Serum levels of cytokines and autoantibodies including Interferon-gamma (IFN-γ), Interleukin-2 (IL-2), Interleukin-4 (IL-4), Interleukin-10 (IL-10), TSH receptor autoantibody (TRAb), thyroid peroxidase antibody (TPOAb) and thyroglobulin antibody(TgAb) were measured by enzyme linked immunosorbent assay(ELISA) in 34 patients with GD and in 33 normal controls. Patients were also divided in two subgroups: 18 cases with ophthalmopathy and 16 cases without ophthalmopathy. Cytokine and antibody responses were analyzed in both groups. Compared with control subjects, patients with GD showed elevated levels of IL-2 and IL-10. IFN-γ levels were lower in patients in comparison to the controls. No significant differences were found between patients and controls regarding the IL-4. There was no statistically significant difference in cytokine levels between those with or without ophthalmopathy. Quantitative-cytokine analysis demonstrated that a combination of Th1 and Th2 cytokines may contribute to the pathogenesis of GD. These results also indicate that IL-10, but not IL-4, is related to the moderate and severe forms of thyroid associated ophthalmophathy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23754356

Source DB:  PubMed          Journal:  Iran J Allergy Asthma Immunol        ISSN: 1735-1502            Impact factor:   1.464


  7 in total

1.  Th1, Th2, and Th17 Cytokine Involvement in Thyroid Associated Ophthalmopathy.

Authors:  Jie Shen; Zhangfang Li; Wenting Li; Ying Ge; Min Xie; Meng Lv; Yanfei Fan; Zhi Chen; Defu Zhao; Yajuan Han
Journal:  Dis Markers       Date:  2015-05-18       Impact factor: 3.434

2.  Expression levels and genetic polymorphisms of interleukin-2 and interleukin-10 as biomarkers of Graves' disease.

Authors:  Cuige Liang; Wenhua DU; Qingyu Dong; Xiaomeng Liu; Wenxia Li; Yueli Wang; Guanqi Gao
Journal:  Exp Ther Med       Date:  2015-01-14       Impact factor: 2.447

3.  MST-4 and TRAF-6 expression in the peripheral blood mononuclear cells of patients with Graves' disease and its significance.

Authors:  Ai Guo; Yan Tan; Chun Liu; Xiaoya Zheng
Journal:  BMC Endocr Disord       Date:  2017-02-20       Impact factor: 2.763

4.  Clinical efficacy of Yingliu mixture combined with metimazole for treating diffuse goitre with hyperthyroidism and its impact on related cytokines.

Authors:  Hua Yang; Yilei Cong; Tengfei Wu; Hong Tang; Muhao Ma; Juanhua Zeng; Wenya Zhang; Zhen Lian; Xinyu Yang
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

5.  HLA-DRA Gene Polymorphisms Are Associated with Graves' Disease as an Autoimmune Thyroid Disease.

Authors:  Peng Du; Jiaoli Zhu; Qiuming Yao; Tiantian Cai; Jianbin Xu; Yudie Fang; Yuqing Wu; Wen Zhang; Jin-An Zhang
Journal:  Biomed Res Int       Date:  2022-09-12       Impact factor: 3.246

6.  Differential profiling of lacrimal cytokines in patients suffering from thyroid-associated orbitopathy.

Authors:  Edina Kishazi; Marianne Dor; Simone Eperon; Aurélie Oberic; Natacha Turck; Mehrad Hamedani
Journal:  Sci Rep       Date:  2018-07-17       Impact factor: 4.379

Review 7.  Genetics, Epigenetics, Cellular Immunology, and Gut Microbiota: Emerging Links With Graves' Disease.

Authors:  Fangyu Zhou; Xin Wang; Lingjun Wang; Xin Sun; Guiqin Tan; Wenwen Wei; Guangbing Zheng; Xiaomin Ma; Dan Tian; Hongsong Yu
Journal:  Front Cell Dev Biol       Date:  2022-01-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.